跳至主要内容
临床试验/NCT01189604
NCT01189604已完成2 期

A Multi-centre, Single-blind, Randomised, Parallel Group, Phase IIb Dose Rate Range Finding Study to Find Maintenance Dose Rate Range of ICI35,868 for the Minimal-to-moderate Sedation on Gastrointestinal Endoscopic Tests (Including Endoscopic Polypectomy)

AstraZeneca1 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2010年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
AstraZeneca
入组人数
123
试验地点
1
主要终点
Modified Observers Assessment of Alertness/Sedation (MOAA/S) Score 2 Minutes From Beginning of Maintenance Period

研究概览

简要总结

Phase IIB study to find the optimal dose rate range of propofol to maintain minimal-to-moderate sedation for diagnostic gastrointestinal endoscopy and gastrointestinal polypectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female (females of child bearing potential to confirm not pregnant via test or contraception)
  • Be undergoing a non-emergent esophagogastroduodenoscopy (EGD) or colonoscopy, including polypectomy that shall be completed within 1 hour

排除标准

  • American Society of Anesthesiologists (ASA) grade III, IV V and VI
  • Baseline oxygen saturation<90% (room air)
  • Body Mass Index (BMI) >=35

研究组 & 干预措施

Arm 3 - ICI35,868 (propofol)

Active Comparator

干预措施: ICI35,868 (propofol) (Drug)

Arm1 - Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Arm 2 - ICI35,868 (propofol)

Active Comparator

干预措施: ICI35,868 (propofol) (Drug)

Arm 4 - ICI35,868 (propofol)

Active Comparator

干预措施: ICI35,868 (propofol) (Drug)

Arm 5 - ICI35,868 (propofol)

Active Comparator

干预措施: ICI35,868 (propofol) (Drug)

Arm 6 - ICI35,868 (propofol)

Active Comparator

干预措施: ICI35,868 (propofol) (Drug)

Arm 7 - ICI35,868 (propofol)

Active Comparator

干预措施: ICI35,868 (propofol) (Drug)

结局指标

主要结局

Modified Observers Assessment of Alertness/Sedation (MOAA/S) Score 2 Minutes From Beginning of Maintenance Period

时间窗: 2 minutes from the beginning of the maintenance period

The MOAA/S is a 6-point ordinal scale measuring a patient's level of sedation. Scores range from 0 (No response to painful stimulus \[trapezius squeeze\]) to 5 (Responds readily to name spoken in normal tone \[awake\]). MOAA/S scores were classified as 0-1, 2-4 and 5.

Modified Observers Assessment of Alertness/Sedation (MOAA/S) Score 4 Minutes From Beginning of Maintenance Period

时间窗: 4 minutes from the beginning of the maintenance period

The MOAA/S is a 6-point ordinal scale measuring a patient's level of sedation. Scores range from 0 (No response to painful stimulus \[trapezius squeeze\]) to 5 (Responds readily to name spoken in normal tone \[awake\]). MOAA/S scores were classified as 0-1, 2-4 and 5.

次要结局

  • Patient Satisfaction With Sedation Instrument (PSSI) Questionnaire(24 - 48 hours after completion of the procedure)
  • Blood Concentrations of Propofol(At the end of the initiation period and every 2 minutes during the maintenance period)
  • Modified Observers Assessment of Alertness/Sedation (MOAA/S) at End of Initiation Period(Last measurement in maintenance period (3 minutes for arms 1-5; 1 minute for arm 6, 5 minute for arm 7))

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验